Canaccord Genuity Starts Inotek Pharmaceuticals (ITEK) at Buy
Tweet
Share
E-mailGet Alerts ITEK Hot Sheet
Price: $3.04 --0%
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 31
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 31
Join SI Premium – FREE
Canaccord Genuity initiated coverage on Inotek Pharmaceuticals (NASDAQ: ITEK) with a Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on Inotek Pharmaceuticals click here. For more ratings news on Inotek Pharmaceuticals click here.
Shares of Inotek Pharmaceuticals closed at $5.75 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy
- RBC Capital Resumes BorgWarner (BWA) at Outperform
- Leerink Starts Latigo Biotherapeutics (LTGO) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
